These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31079796)

  • 1. Current Immunotherapy Practices in Melanoma.
    Rothermel LD; Sarnaik AA; Khushalani NI; Sondak VK
    Surg Oncol Clin N Am; 2019 Jul; 28(3):403-418. PubMed ID: 31079796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment patterns of advanced malignant melanoma (stage III-IV) - A review of current standards in Europe.
    Harries M; Malvehy J; Lebbe C; Heron L; Amelio J; Szabo Z; Schadendorf D
    Eur J Cancer; 2016 Jun; 60():179-89. PubMed ID: 27118416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of immunotherapy among patients with stage 4 melanoma: An analysis of the National Cancer Database from 2012 to 2016.
    Shah PV; Choi JN; Fiessinger L; Nardone B; Nguyen CV; Liszewski W
    J Am Acad Dermatol; 2021 Mar; 84(3):811-814. PubMed ID: 32553633
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of immune checkpoint inhibitors and novel immunotherapies in uveal melanoma.
    Jindal V
    Chin Clin Oncol; 2018 Feb; 7(1):8. PubMed ID: 29486567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic melanoma and immunotherapy.
    Herzberg B; Fisher DE
    Clin Immunol; 2016 Nov; 172():105-110. PubMed ID: 27430520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing the immune system for the treatment of melanoma: current status and future prospects.
    Guennoun A; Sidahmed H; Maccalli C; Seliger B; Marincola FM; Bedognetti D
    Expert Rev Clin Immunol; 2016 Aug; 12(8):879-93. PubMed ID: 27070898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies.
    Komatsubara KM; Carvajal RD
    Curr Oncol Rep; 2017 Jul; 19(7):45. PubMed ID: 28508938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Principles of Immunotherapy in Melanoma.
    Onitilo AA; Wittig JA
    Surg Clin North Am; 2020 Feb; 100(1):161-173. PubMed ID: 31753110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of uveal melanoma.
    Bosch JJ
    Dev Ophthalmol; 2012; 49():137-149. PubMed ID: 22042018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel immunotherapies for the treatment of melanoma.
    Gato-Cañas M; Arasanz H; Blanco-Luquin I; Glaría E; Arteta-Sanchez V; Kochan G; Escors D
    Immunotherapy; 2016 May; 8(5):613-32. PubMed ID: 27140413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New melanoma immunotherapies: mechanisms of action, efficiency and management of toxicities].
    Moura B; Homicsko K; Berthod G; Cerottini JP; Guggisberg D; Gaide O; Maillard MH; Michielin O
    Rev Med Suisse; 2015 May; 11(475):1108, 1110-4. PubMed ID: 26152085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for melanoma.
    Weber J
    Curr Opin Oncol; 2011 Mar; 23(2):163-9. PubMed ID: 21192262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intralesional and systemic immunotherapy for metastatic melanoma.
    Luu C; Khushalani NI; Zager JS
    Expert Opin Biol Ther; 2016 Dec; 16(12):1491-1499. PubMed ID: 27602429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy for advanced melanoma: Current knowledge and future directions.
    Nakamura K; Okuyama R
    J Dermatol Sci; 2016 Aug; 83(2):87-94. PubMed ID: 27302423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Call to Arms: Surgeons Must Play an Important and Early Role in the Management of Patients with Advanced Melanoma.
    Lowe MC; Delman KA
    Ann Surg Oncol; 2019 Dec; 26(13):4180-4181. PubMed ID: 31468220
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunotherapy Combinations With Checkpoint Inhibitors in Metastatic Melanoma: Current Approaches and Future Directions.
    Atkins M
    Semin Oncol; 2015 Dec; 42 Suppl 3():S12-9. PubMed ID: 26598055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy in melanoma: Recent advances and future directions.
    Franklin C; Livingstone E; Roesch A; Schilling B; Schadendorf D
    Eur J Surg Oncol; 2017 Mar; 43(3):604-611. PubMed ID: 27769635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of metastatic mucosal melanoma to immunotherapy: It can get worse before it gets better.
    Atrash S; Makhoul I; Mizell JS; Hutchins L; Mahmoud F
    J Oncol Pharm Pract; 2017 Apr; 23(3):215-219. PubMed ID: 26811403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Promise of Molecularly Targeted and Immunotherapy for Advanced Melanoma.
    Margolin K
    Curr Treat Options Oncol; 2016 Sep; 17(9):48. PubMed ID: 27461037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma Immunotherapy in the Elderly.
    Orloff M
    Curr Oncol Rep; 2018 Mar; 20(2):20. PubMed ID: 29500787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.